NO970373D0 - Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes - Google Patents

Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes

Info

Publication number
NO970373D0
NO970373D0 NO970373A NO970373A NO970373D0 NO 970373 D0 NO970373 D0 NO 970373D0 NO 970373 A NO970373 A NO 970373A NO 970373 A NO970373 A NO 970373A NO 970373 D0 NO970373 D0 NO 970373D0
Authority
NO
Norway
Prior art keywords
benzoxazoles
diabetes
treatment
type
pyridine derivatives
Prior art date
Application number
NO970373A
Other languages
English (en)
Other versions
NO970373L (no
NO307827B1 (no
Inventor
David Haigh
Harshad Kantilal Rami
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415330A external-priority patent/GB9415330D0/en
Priority claimed from GBGB9425599.9A external-priority patent/GB9425599D0/en
Priority claimed from GBGB9509923.0A external-priority patent/GB9509923D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO970373D0 publication Critical patent/NO970373D0/no
Publication of NO970373L publication Critical patent/NO970373L/no
Publication of NO307827B1 publication Critical patent/NO307827B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO970373A 1994-07-29 1997-01-28 Benzoksazol- og pyridinderivater, anvendelse av dem og farmasøytisk preparat inneholdende dem NO307827B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9415330A GB9415330D0 (en) 1994-07-29 1994-07-29 Novel compounds
GBGB9425599.9A GB9425599D0 (en) 1994-12-19 1994-12-19 Novel compounds
GBGB9509923.0A GB9509923D0 (en) 1995-05-17 1995-05-17 Novel compounds
PCT/GB1995/001323 WO1996004261A1 (en) 1994-07-29 1995-06-07 Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes
PCT/EP1995/003038 WO1996004260A1 (en) 1994-07-29 1995-07-28 Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes

Publications (3)

Publication Number Publication Date
NO970373D0 true NO970373D0 (no) 1997-01-28
NO970373L NO970373L (no) 1997-03-18
NO307827B1 NO307827B1 (no) 2000-06-05

Family

ID=27267309

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970373A NO307827B1 (no) 1994-07-29 1997-01-28 Benzoksazol- og pyridinderivater, anvendelse av dem og farmasøytisk preparat inneholdende dem

Country Status (16)

Country Link
EP (1) EP0772605A1 (no)
AP (1) AP776A (no)
BR (1) BR9508468A (no)
CA (1) CA2196079A1 (no)
CZ (1) CZ25497A3 (no)
DZ (1) DZ1916A1 (no)
FI (1) FI970357A (no)
HU (1) HUT76637A (no)
IL (3) IL114759A (no)
MA (1) MA23632A1 (no)
MX (1) MX9700763A (no)
NO (1) NO307827B1 (no)
OA (1) OA10470A (no)
PL (1) PL318766A1 (no)
SK (1) SK12297A3 (no)
WO (2) WO1996004261A1 (no)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
DE69725585T2 (de) * 1996-04-04 2004-07-01 Sankyo Co., Ltd. Phenylalkylcarbonsäure-derivate
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
PL339660A1 (en) 1997-10-02 2001-01-02 Sankyo Co Derivatives of amidocarboxylic acids
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6265401B1 (en) 1997-10-27 2001-07-24 Reddy-Cheminor, Inc. Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
BR9812770A (pt) 1997-10-27 2000-12-12 Reddy Research Foundation Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
CN1280574A (zh) 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
MXPA00004036A (es) * 1997-10-27 2006-05-24 Reddys Lab Ltd Dr Compuestos triciclicos novedosos y su uso en medicina; proceso para su preparacion y composiciones farmaceuticas que los contienen..
WO1999019313A1 (en) * 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
US6444816B1 (en) 1997-10-27 2002-09-03 Dr. Reddy's Research Foundation Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
NZ504106A (en) * 1998-05-27 2003-02-28 Dr Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
TR200100773T2 (tr) 1998-09-17 2001-07-23 Bristol-Myers Squibb Company Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı diyabet tedavi yöntemi
US6214820B1 (en) 1998-10-21 2001-04-10 Novo Nordisk A/S Compounds, their preparation and use
JP2002527516A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、それらの製造及び使用
WO2000023415A1 (en) * 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
JP2002527503A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物類、それらの調製及び使用
US6365586B1 (en) 1998-10-21 2002-04-02 Novo Nordisk A/S Compounds, their preparation and use
US6300339B1 (en) 1998-10-21 2001-10-09 Novo Nordisk A/S Compounds, their preparation and use
EP1123279A1 (en) * 1998-10-21 2001-08-16 Novo Nordisk A/S New compounds, their preparation and use
WO2000023416A1 (en) * 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
US6468996B1 (en) 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
US6248781B1 (en) 1998-10-21 2001-06-19 Novo Nordisk A/S Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
JP2002527520A (ja) * 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ 新規化合物、その製造及び使用
UA60386C2 (uk) 1998-10-29 2003-10-15 Reddys Laboratories Ltd Спосіб одержання похідних 3-[4-[2-(феноксазин-10-іл)метокси]феніл]пропіонової кислоти (варіанти) та проміжні сполуки для їх отримання
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
AU4465200A (en) * 1999-04-16 2000-11-02 Dr. Reddy's Research Foundation Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
US6369055B1 (en) 1999-04-20 2002-04-09 Novo Nordisk A/S Compounds, their preparation and use
JP2002542218A (ja) * 1999-04-20 2002-12-10 ノボ ノルディスク アクティーゼルスカブ 新規な化合物、それらの製造および使用
US6972294B1 (en) 1999-04-20 2005-12-06 Novo Nordisk, A/S Compounds, their preparation and use
EP1171438A1 (en) 1999-04-20 2002-01-16 Novo Nordisk A/S Compounds, their preparation and use
US7414128B2 (en) 1999-04-20 2008-08-19 Dr. Reddy's Laboratories, Limited Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate
US6274608B1 (en) 1999-04-20 2001-08-14 Novo Nordisk A/S Compounds, their preparation and use
WO2000063190A1 (en) * 1999-04-20 2000-10-26 Novo Nordisk A/S New compounds, their preparation and use
SK15092001A3 (sk) * 1999-04-28 2002-05-09 Dr. Reddy's Research Foundation Substituované bicyklické heterocyklické zlúčeniny, spôsob ich prípravy a ich použitie ako antiobezitných a hypocholesterolemických činidiel
PT1206457E (pt) 1999-08-27 2004-03-31 Lilly Co Eli Derivados de diaril-oxa(tia)zol e seu uso como moduladores dos ppars
BRPI0108024B8 (pt) * 2000-01-19 2021-05-25 Cadila Healthcare Ltd composto, processo para a preparação de um composto, composição farmacêutica, uso do composto, novo intermediário e processo para a preparação de um novo intermediário
US6555577B1 (en) 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
US6569901B2 (en) 2000-01-28 2003-05-27 Novo Nordisk A/S Alkynyl-substituted propionic acid derivatives, their preparation and use
CN1396904A (zh) * 2000-01-28 2003-02-12 诺沃挪第克公司 新颖的化合物、它们的制备和用途
US6509374B2 (en) 2000-04-17 2003-01-21 Novo Nordisk A/S Compounds, their preparation and use
AU2001261503A1 (en) * 2000-05-12 2001-11-26 Ortho-Mcneil Pharmaceutical, Inc. Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators
US6908908B2 (en) 2000-05-12 2005-06-21 Ortho-Mcneil Pharmaceutical, Inc. Biologically active 4H-benzo [1,4] oxazin-3-ones
US6599899B2 (en) 2000-05-12 2003-07-29 Ortho-Mcneil Pharmaceutical, Inc. Benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
ES2288957T3 (es) * 2000-05-12 2008-02-01 Ortho-Mcneil Pharmaceutical, Inc. 4h-benzo(1.4)oxazin-3-ina biologicamente activas.
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7067530B2 (en) 2001-07-30 2006-06-27 Novo Nordisk A/S Compounds, their preparation and use
US6869967B2 (en) 2001-07-30 2005-03-22 Novo Nordisk A/S Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
US7220877B2 (en) 2001-10-17 2007-05-22 Novo Nordisk A/S Compounds, their preparation and use
JP2005518408A (ja) 2001-12-29 2005-06-23 ノボ　ノルディスク　アクティーゼルスカブ 異常脂肪血症を治療するための、ｇｌｐ−１化合物と他の薬物との組み合わせ使用
US7015345B2 (en) 2002-02-21 2006-03-21 Asahi Kasei Pharma Corporation Propionic acid derivatives
US7816385B2 (en) 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
US6653334B1 (en) 2002-12-27 2003-11-25 Kowa Co., Ltd. Benzoxazole compound and pharmaceutical composition containing the same
JPWO2008139879A1 (ja) * 2007-04-26 2010-07-29 ファルマフロンティア株式会社 Ｇ蛋白質共役型レセプター抑制剤および医薬
BR112013019352A2 (pt) 2011-01-31 2020-07-14 Cadila Healthcare Limited método para o tratamento de lipodistrofia, uso de um composto, dosagem diária, método de tratamento, composição farmacêutica, uso da composição farmacêutica e composto
WO2014174524A1 (en) 2013-04-22 2014-10-30 Cadila Healthcare Limited A novel composition for nonalcoholic fatty liver disease (nafld)
ES2889916T3 (es) 2013-05-30 2022-01-14 Cadila Healthcare Ltd Un procedimiento para la preparación de pirroles con actividades hipolipidémicas e hipocolesterémicas
TW201513857A (zh) 2013-07-05 2015-04-16 Cadila Healthcare Ltd 協同性組成物
IN2013MU02470A (no) 2013-07-25 2015-06-26 Cadila Healthcare Ltd
IN2013MU02905A (no) 2013-09-06 2015-07-03 Cadila Healthcare Ltd
WO2017064635A2 (en) 2015-10-14 2017-04-20 Cadila Healthcare Limited Pyrrole compound, compositions and process for preparation thereof
WO2018104916A1 (en) 2016-12-09 2018-06-14 Cadila Healthcare Limited Treatment for primary biliary cholangitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089514A (en) * 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
WO1994001420A1 (en) * 1992-07-03 1994-01-20 Smithkline Beecham Plc Heterocyclic compounds as pharmaceutical

Also Published As

Publication number Publication date
IL114759A0 (en) 1995-12-31
CZ25497A3 (en) 1997-09-17
HUT76637A (en) 1997-10-28
MX9700763A (es) 1997-05-31
FI970357A (fi) 1997-03-26
AP9700918A0 (en) 1997-01-31
SK12297A3 (en) 1997-08-06
NO970373L (no) 1997-03-18
CA2196079A1 (en) 1996-02-15
FI970357A0 (fi) 1997-01-28
OA10470A (en) 2002-04-08
WO1996004260A1 (en) 1996-02-15
EP0772605A1 (en) 1997-05-14
IL114759A (en) 1999-10-28
NO307827B1 (no) 2000-06-05
MA23632A1 (fr) 1996-04-01
IL125525A (en) 2000-02-29
WO1996004261A1 (en) 1996-02-15
IL125525A0 (en) 1999-03-12
BR9508468A (pt) 1997-11-25
AP776A (en) 1999-10-28
PL318766A1 (en) 1997-07-07
DZ1916A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
NO970373D0 (no) Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
NO942720D0 (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
NO940277D0 (no) Triglycerider og blandinger av slike
NO962179D0 (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
NO974365D0 (no) Fremgangsmåte og krystallformer av 2-metyl-thieno-benzodiazepin
DE59609556D1 (de) Zahnstangengetriebe
NO964102D0 (no) Farmasöytiske preparater og medikamenter for forebyggelse og behandling av endotheliale dysfunksjoner
BR9609445A (pt) Derivados de azetidinona no tratamento de aterosclerose
DK0767666T3 (da) Fremgangsmåder og præparater, der er anvendelige ved profylakse og behandling af endotoksin-relaterede tilstande
FI964912A (fi) Parannuksia elintarviketuotteiden valmistamiseen ja siihen liittyen
NO972426D0 (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
FI964911A0 (fi) Parannuksia elintarviketuotteiden valmistamiseen ja siihen liittyen
NO964541D0 (no) Porphacyanin og CNC-utvidete porphyriner
NO964551D0 (no) Imidazolderivater og fremgangsmåte for fremstilling av slike
NO993738D0 (no) 2-amino-substituerte pyridiner som kan anvendes ved behandling ved arteriosclerose og hyper-lipoproteinemi
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
NO996264L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20000229D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
IS4140A (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
NO20011901D0 (no) Antikonvulsive derivater nyttige ved behandling av alkoholavhengighet og -misbruk

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003